Marella Thorell
Independent DirectorMs. Marella Thorell, CPA serves as an Independent Director of Carisma Therapeutics, Inc. since June 30, 2024. She was Chief Financial Officer of Seres Therapeutics, Inc. from March 25, 2024 until November 15, 2026 and served as its Treasurer until November 15, 2026 and served as its Co-CEO from July 31, 2025 until March 02, 2026 and served as Co-President since August 1, 2025 until March 02, 2026 and serves as its Executive Vice President since 2026. She was Executive Vice President of Seres Therapeutics, Inc. from March 25, 2024 to July 31, 2025. She served as Chief Financial Officer of Evelo Biosciences, Inc. since September 2022 until November 20, 2023 and served as its Senior Vice President and Principal Financial Officer until November 20, 2023. She also served as Secretary, Treasurer and Principal Accounting Officer of Evelo Biosciences, Inc. until November 20, 2023. She served at Evelo Biosciences, Inc. until December 1, 2023. She served as Chief Accounting Officer at Centessa Pharmaceuticals plc, since April 2021 until July 31, 2022 and served as its Head of Finance since January 2021 until April 2021. In this role, Ms. Thorell led the establishment of finance operations, directed its public company readiness activities in connection with its initial public offering and managed its accounting and financial reporting functions. She serves as Independent Non-Executive Director at Vallon Pharmaceuticals, Inc. since February 12, 2021 and serves as its Chairperson since May 16, 2022. Ms. Thorell was Chief Financial Officer of Palladio Biosciences since October 11, 2019 until January 2021. At Palladio, Ms. Thorell led finance operations and capital strategy and execution, including the acquisition of Palladio by Centessa. She was Chief Financial Officer and Chief Operating Officer of Realm Therapeutics plc since December 2016 until July 2019. She had been the Chief Financial Officer of Realm Therapeutics plc since March 2013 until December 2016 and had been its Company Secretary since October 07, 2011. She served as Chief Financial Officer of PuriCore since March 2013 until December 2016. Ms. Thorell had been the Chief Operating Officer of Realm Therapeutics plc since October 2014 until December 2016. She served as a Finance Director and Vice President of Human Resources & Administration at Realm Therapeutics plc. Ms. Thorell joined Realm Therapeutics plc in October 2008, having served as a consultant. At Realm, Ms. Thorell was responsible for in-licensing and out-licensing assets and capital strategy to fund growth and clinical development. Prior to Realm Therapeutics plc, she was the Principal of Thorell Consulting. Ms. Thorell served as Director of Human Resources at Campbell Soup Company, supporting the sales, marketing, finance and information technology departments. She transferred into Human Resources after serving in the Company's Corporate Audit function providing advice within Campbell's global operations. She served as Director of ESSA Pharma Inc. since July 31, 2019 until October 09, 2025. She had been Executive Director of Realm Therapeutics plc since March 5, 2013. She began her career and earned her CPA designation with Ernst & Young, LLP in Philadelphia. Ms. Thorell is also on the Board of Directors of Living Beyond Breast Cancer (lbbc.org). Ms. Thorell earned a B.S. in Business (accounting) from Lehigh University, magna cum laude.
Positions
- Company NameCarisma Therapeutics, Inc.Stock CodeCARMPositionIndependent Director
